Example: Heart Attack

Search clinical trials for: Clemastine

Total 12 results

NCT05359653

Not yet recruiting

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Conditions: Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign
NCT03109288

Recruiting

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Conditions: Multiple Sclerosis
NCT05131828

Recruiting

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Conditions: Multiple Sclerosis
NCT05338450

Not yet recruiting

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis

Conditions: Multiple Sclerosis, Internuclear Ophthalmoplegia
NCT02521311

Recruiting

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Conditions: Optic Neuritis
NCT02040298

Completed

Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis

Conditions: Multiple Sclerosis, Relapsing-Remitting
NCT03826004

Completed

Clemastine in Cardiovascular Surgery

Conditions: Efficacy and Safety
NCT00913549

Completed

To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Conditions: Allergy
NCT02613091

Completed

Effect of Clemastine Fumarate on Color Vision in Healthy Controls

Conditions: Healthy Subjects
NCT00481676

Completed

Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria

Conditions: Chronic Urticaria
NCT01239719

Unknown status

Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

Conditions: Allergy, Dermatitis
NCT01125761

Withdrawn

Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

Conditions: Dermatitis

Search clinical trials for: Clemastine

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations